BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8492132)

  • 1. Effects of chronic morphine treatment on beta-endorphin-related peptides in the caudal medulla and spinal cord.
    Bronstein DM; Gutstein HB; Akil H
    J Neurochem; 1993 Jun; 60(6):2304-7. PubMed ID: 8492132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats.
    Gudehithlu KP; Tejwani GA; Bhargava HN
    Brain Res; 1991 Jul; 553(2):284-90. PubMed ID: 1933285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and posttranslational regulation of beta-endorphin biosynthesis in the CNS: effects of chronic naltrexone treatment.
    Bronstein DM; Day NC; Gutstein HB; Trujillo KA; Akil H
    J Neurochem; 1993 Jan; 60(1):40-9. PubMed ID: 8417165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morphine treatment on pro-opiomelanocortin systems in rat brain.
    Bronstein DM; Przewlocki R; Akil H
    Brain Res; 1990 Jun; 519(1-2):102-11. PubMed ID: 2144463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-endorphin processing and cellular origins in rat spinal cord.
    Gutstein HB; Bronstein DM; Akil H
    Pain; 1992 Nov; 51(2):241-247. PubMed ID: 1336592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ketamine and its interactions with morphine and nalbuphine on the level of enkephalins in some parts of the brain and spinal cord.
    Kołada I; Kmieciak-Kołada K; Huzarska M; Dyaczyńska-Herman A; Herman ZS
    Pol J Pharmacol; 1994; 46(3):139-46. PubMed ID: 8000445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic treatment with morphine, midazolam, and both together on beta-endorphin levels in the rat.
    Rattan AK; Tejwani GA
    Brain Res Bull; 1996; 41(6):335-41. PubMed ID: 8973837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord.
    Sheu MJ; Sribanditmongkol P; Santosa DN; Tejwani GA
    Brain Res; 1995 Mar; 675(1-2):31-7. PubMed ID: 7796144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSG effects on beta-endorphin and alpha-MSH in the hypothalamus and caudal medulla.
    Alessi NE; Quinlan P; Khachaturian H
    Peptides; 1988; 9(4):689-95. PubMed ID: 2852357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular beta-endorphin but not morphine in anesthetized rats.
    Tseng LF; Higgins MJ; Hong JS; Hudson PM; Fujimoto JM
    Brain Res; 1985 Sep; 343(1):60-9. PubMed ID: 2864105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat.
    Hammond DL; Presley R; Gogas KR; Basbaum AI
    J Comp Neurol; 1992 Jan; 315(2):244-53. PubMed ID: 1545011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesia, development of tolerance, and 5-hydroxytryptamine turnover in the rat after cerebral and systemic administration of morphine.
    Vasko MR; Vogt M
    Neuroscience; 1982 May; 7(5):1215-25. PubMed ID: 6180353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic treatment with morphine, midazolam and both together on dynorphin(1-13) levels in the rat.
    Rattan AK; Tejwani GA
    Brain Res; 1997 Apr; 754(1-2):239-44. PubMed ID: 9134981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma beta-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal.
    Antonio Martínez J; Vargas ML; Fuente T; Del Rio Garcia J; Milanés MV
    Eur J Pharmacol; 1990 Jun; 182(1):117-23. PubMed ID: 2144820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
    Bhargava HN; Gulati A
    Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat.
    Bhargava HN; Larsen AK; Rahmani NH; Villar VM
    Brain Res; 1993 Apr; 607(1-2):1-8. PubMed ID: 8481789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: an in vivo microdialysis study.
    Lucas GA; Hoffmann O; Alster P; Wiesenfeld-Hallin Z
    Brain Res; 1999 Mar; 821(1):79-86. PubMed ID: 10064790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine.
    Gudehithlu KP; Bhargava HN
    Peptides; 1995; 16(3):415-9. PubMed ID: 7651893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of beta-endorphin-related peptides in the caudal medulla oblongata and hypothalamus of the prenatal, postnatal and adult rat.
    Quinlan PE; Alessi NE
    Brain Res Dev Brain Res; 1991 Sep; 62(1):1-5. PubMed ID: 1760865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.